Johnson Wendy S. 4
4 · Reneo Pharmaceuticals, Inc. · Filed Jul 9, 2021
Insider Transaction Report
Form 4
Johnson Wendy S.
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2021-07-08$1.97/sh+111,736$220,120→ 111,736 total - Exercise/Conversion
Stock option (right to buy)
2021-07-08−111,736→ 0 totalExercise: $1.97From: 2017-09-01Exp: 2028-04-04→ Common Stock (111,736 underlying)